The Department of the Army Medical Command awarded a $2.7 million firm fixed-price purchase order to Gen-Probe Incorporated Gen-Probe Sales & Service, Inc. Division for 250 test kits of the SARS-COV-2 assay per kit. The contract is being funded through the Army's medical research programs focused on responding to the coronavirus COVID-19 pandemic and supporting testing capacity. Performance will occur at the Aberdeen Proving Ground in Maryland through December 2021. No subcontractors or...
The Department of the Army Medical Command awarded a $518,400 purchase order to Gen-Probe Incorporated Gen-Probe Sales & Service, Inc. Division for reagents and assays in support of the Coronavirus COVID-19 national interest. The contract was awarded under the agency's $20 million Coronavirus program and will provide the requested products for use at the prime contractor's location in Marlborough, Massachusetts between April 6th and 17th, 2020. A firm fixed price was established for this...
The Department of Defense - Army Medical Command awarded a $492,007.20 firm fixed price delivery order contract to Gen-Probe Incorporated Gen-Probe Sales & Service, Inc. Division to provide SARS COV-2 assay test kits for Tripler Army Medical Center in Hawaii. The contract has a period of performance starting on August 26, 2022 through September 30, 2022 with all work to be completed in Marlborough, Massachusetts. Gen-Probe Incorporated is a medical diagnostics company that produces molecular...
This federal contract award to Gen-Probe Incorporated, a medical diagnostics company, is for the delivery of PANTHER FUSION SARS-COV2 ASSAY PPR SOLUTION (test kits) and DNA/RNA ENZYME CARTRIDGE (reagent) kits in support of the COVID-19 response. The $1,800,000.00 firm fixed-price delivery order was issued by the Medical Command (MEDCOM) of the U.S. Department of the Army. The contract has no set-aside designation. Gen-Probe, a large specialized supplier in molecular diagnostics, has held...
The Department of Defense, Army Medical Command awarded a $1.8 million firm fixed price purchase order to Gen-Probe Incorporated Gen-Probe Sales & Service, Inc. Division for COVID-19 testing services. The contract will provide testing to be performed at Fort Campbell, Kentucky through September 2022 in support of the Army Medical Command's medical response efforts. No subcontractors or set aside designations were identified. The award was made using the Army Medical Command's purchasing...
<p>The Department of the Army Medical Command awarded a $405,367.50 firm fixed-price delivery order contract to Gen-Probe Incorporated for 1001 coronavirus/novel coronavirus reagent tests. The contract has a period of performance through September 30, 2022 for tests to be delivered to Madigan Army Medical Center in Lakewood, Washington. No set-aside provisions were applied to this award made under an existing vehicle to support the Medical Command's medical diagnostic testing requirements.</p>
The Department of the Army Medical Command awarded a $19.5 million delivery order to Gen-Probe Incorporated Gen-Probe Sales & Service, Inc. Division for PANTHER FUSION SARS-COV-2 PRIMER PROBE MIX AND CONSUMABLE ITEMS. The products will support the Army's COVID-19 response efforts and will be delivered to a location in San Antonio, Texas under the firm fixed price contract scheduled to run from April 2020 through April 2021. No set aside designation or subcontractors were indicated. The award...
Gen-Probe Incorporated, operating through its Gen-Probe Sales & Service division, has been awarded a $16.2 million firm fixed price delivery order contract by the Department of the Army Medical Command to provide COVID-19 PANTHER Fusion test kits. The test kits will support the Army's medical response to the coronavirus pandemic and will be delivered to a facility in Fort Sam Houston, Texas. No subcontractors or set aside designations were identified. The contract was funded under the Army's...
This firm fixed-price purchase order was awarded by the Medical Command (MEDCOM) component of the U.S. Army to Gen-Probe Incorporated, a large medical diagnostics company, for the provision of nucleic acid probe test kits. The $1,550,250.00 contract has an ultimate completion date of September 30, 2020. Gen-Probe Incorporated, the prime contractor, is a for-profit organization that specializes in molecular diagnostic testing systems, assays, and related products and services for the U.S. federal...
<p>The Defense Health Agency (DOD) awarded a $745,185 purchase order to Gen-Probe Incorporated Gen-Probe Sales & Service, Inc. Division for APTIMA SARS-COV-2 ASSAY KITS. The firm fixed price contract will provide coronavirus COVID-19 testing kits to support national interest actions in Japan, with performance taking place from May 10, 2022 through June 1, 2022.</p>